Home » Topics » Disease categories and therapies » Dental

Dental
RSS

Acologix expands AC-100 phase II development for periodontal bone loss

May 30, 2005

Acologix advances AC-100 into phase II in dentistry

May 10, 2005

BioMimetic's GEM-21S recommended for approval

July 20, 2004

PMA for GEM-21S accepted for review

May 7, 2004

Enrollment under way in phase III Periostat MR study for adult periodontitis

April 13, 2004

BioMimetic Pharmaceuticals and Luitpold Pharmaceuticals establish alliance

Jan. 14, 2004

Inhibitors of Arg- and Lys-gingipain and their use in periodontitis therapy

June 20, 2003

Periostat approved in Canada

April 8, 2003

New data on subantimicrobial doses of Periostat discussed in San Antonio

March 25, 2003

Arestin approved in Sweden

Jan. 24, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...